首页> 外文期刊>Clinical Endocrinology >Lanreotide autogel-induced tumour shrinkage in thyrotropin-secreting pituitary macroadenomas.
【24h】

Lanreotide autogel-induced tumour shrinkage in thyrotropin-secreting pituitary macroadenomas.

机译:兰瑞肽自凝胶诱导的促甲状腺激素分泌垂体大腺瘤中的肿瘤缩小。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We read with great interest the paper by Trevor A. Howlett et a} on autoimmune hypophysitis and we found it very important for management of this disorder. Autoimmune hypophysitis with clinical features of a pituitary mass is a rare event. We believe that a subclinical form of this disease is much more frequent in clinical practice. We have in our observation a group of 305 patients with idiopathic isolated secondary adrenal insufficiency. Interestingly, 203 (67%) of them had associated various autoimmune disorders.2 Apart from the well-known hypothalamic-pituitary-adrenal suppression because of exogenous corticosteroids, only an autoimmune mechanism is able to influence selectively the secretory function of the corticotrophs in adult patients.
机译:我们非常感兴趣地阅读了Trevor A. Howlett等人关于自身免疫性垂体炎的论文,我们发现它对于控制这种疾病非常重要。具有垂体肿块临床特征的自身免疫性垂体炎很少见。我们认为这种疾病的亚临床形式在临床实践中更为常见。在我们的观察中,有305例患有特发性孤立性继发性肾上腺功能不全的患者。有趣的是,其中有203种(67%)与各种自身免疫性疾病相关。2除了众所周知的由于外源性皮质类固醇引起的下丘脑-垂体-肾上腺抑制外,只有一种自身免疫机制能够选择性地影响成人皮质类固醇的分泌功能。耐心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号